Controversy over mammographic screening.

Screening for prostate cancer: Controversy? What controversy?

for the absence of a reduction in mortality in the plco trial and in comparison with the difference seen in the erspc trial. The truth of the matter is the psa test should not be used at all in screening for prostate cancer in the manner it has heretofore been used. Prostate-specific antigen, discovered in 1970 5,6 , is a normal component of the prostate. It is not cancer-specific. Rather, it i...

Controversy over BCG Vaccination

Controversy over BCG Vaccination

Mammographic Screening for Breast Cancer

1. Reisberg B, Doody R, Stöffler A, et al. Memantine in moderateto-severe Alzheimer’s disease. N Engl J Med 2003;348:1333-4. 2. Kornhuber J, Bormann J, Retz W, Hübers M, Riederer P. Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 1989;166:589-90. 3. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for de...

Improving rates of mammographic screening.